In Vitro Fertilization Test Market Size to Surpass USD 4.7 Billion by 2030

The global In Vitro Fertilization Test Market was reached USD 2.5 billion in 2021 and it is expected to surpass USD 4.7 billion by the end of 2030 with a CAGR of 7.0% during the prediction period 2022 to 2030.

This report analyzes the current and future prospects of the global in vitro fertilization test market. Increase in population with infertility issues, in vitro fertilization success rates, inclination toward delayed pregnancies, number of fertility clinics across the globe, and fertility tourism is a key factor projected to fuel the growth of the global in vitro fertilization test market during the forecast period.

The report provides an elaborate executive summary, which comprises a snapshot of the various segments of the global in vitro fertilization test market. The report also provides information and data analysis of the global in vitro fertilization test market about segments based on test type, end user, and region.

Get the sample copy of report@ https://www.novaoneadvisor.com/report/sample/6294

The overview section of the report provides detailed qualitative analysis of drivers and restraints impacting the global in vitro fertilization test market, along with opportunities in the global market Additionally, the global in vitro fertilization test market report includes company profiles and competitive matrix, which provide data about their businesses, product portfolios, and competitive landscape in the global in vitro fertilization test market

The report includes data analysis on the in vitro fertilization test market attractiveness by region and segments

The last section of the report provides quantitative and qualitative analysis on market share of key players operating in the global in vitro fertilization test market. It elaborates on the key competitive strategies adopted by the major industry players, thereby presenting a thorough understanding of the competitive scenario in the global in vitro fertilization test market.

The surge in inclination toward delayed pregnancies, number of fertility clinics across the globe, and fertility tourism is anticipated to drive the global in vitro fertilization test market from 2022 to 2030. Europe is expected to account for a significant share of the global in vitro fertilization test market during the forecast period. The extent of usage varies widely across countries in Europe, which can be attributed to legislation, affordability, reimbursement, and norms surrounding childbearing and conception. The adoption of ART legislation in Europe has increased over the past few years, with all countries having some form of legislation. Countries with complete coverage of treatments via national health plans, such as the U.K., Spain, and Italy have the highest level of ART utilization.

The market in Asia Pacific is likely to expand at a high CAGR from 2022 to 2030. Increase in patient awareness about fertility treatments, rise in infertility issues owing to changing lifestyle, high stress level, and delayed pregnancy are the key factors propelling the market in Asia Pacific.

Ask here for customization@ https://www.novaoneadvisor.com/report/customization/6294

Decline in Fertility Rates to Propel Market

Over the past few decades, fertility patterns across the world have changed dramatically. The global fertility rate has touched unprecedented low levels. According to a report published by the United Nations (UN), the global fertility rate declined from 3.2 live births per woman in 1990 to 2.5 in 2019. Europe has the lowest fertility rate of 1.7 children per woman. The global fertility rate is expected to decline to 2.4 children per woman by 2030 and 2.2 children per woman by 2050.

According to Child Trend, a non-profit research organization, fertility rates in the U.S. declined sharply during the ‘baby boomer’ years of the 1950s, early 1960s, and 1976 (118 and 65 births per 1,000 women of childbearing age for 1960 and 1976, respectively). Since the 1970s, fertility rates have been relatively stable, varying between 64 and 71 births per 1,000 women. There were small peaks in 1990 and 2007, but rates have dropped since then. They are the lowest in the recent history, standing at 63 births per 1,000 women in 2013.

According to the Department of Family & Community Services Australia, fertility in Australia has been decreasing for a considerable time. The replacement fertility rate is around 2.1. The total fertility rate (TFR) was at its maximum level (3.6) observed in the 20th century in 1961. Throughout the 1970s and 1980s, TFR fluctuated around 1.8 or 1.9, with a small but steady decline throughout the 1990s. In 1999, Australia’s TFR was 1.75, dropping from 1.76 of the previous year. This was the minimum level observed in the 20th Century.

Preimplantation Genetic Testing to Dominate Global Market

In terms of test type, the global in vitro fertilization test market has been classified into sperm aneuploidy test, genetic compatibility test, preimplantation genetic testing, endometrial receptivity analysis, noninvasive prenatal testing, and others. The preimplantation genetic testing (PGD) segment is expected to dominate the global in vitro fertilization test market from 2022 to 2030. The usage of PGD for chromosomal aberrations, aneuploidy screening, gender selection, single gene disorder, HLA typing, and X-linked diseases has been increasing rapidly due to benefits associated with better pregnancy rate and birth of a healthy child. Aneuploidy screening using PGD has eased the method of detecting the risk of a syndrome caused due to variation in the number of chromosomes. This is expected to drive the segment during the forecast period.

Fertility Clinics to be Major End Users

Based on end user, the global in vitro fertilization test market has been divided into fertility clinics, hospitals, and others. The fertility clinics segment is likely to account for a significant share of the global in vitro fertilization test market by 2030. Rise in fertility tourism and insurance coverage and government initiatives in registration of fertility clinics to provide safe and high quality IVF treatments are likely to fuel the growth of the fertility clinics segment.

Some of the prominent players in the In Vitro Fertilization Test Market include:

• CooperSurgical, Inc.
• Esco Micro Pte Ltd.
• FUJIFILM Irvine Scientific
• Hamilton Thorne, Inc.
• Vitrolife AB
• IVFtech ApS
• Nidacon International AB
• Igenomix
• Thermo Fisher Scientific
• Cook
• Genea Biomedx
• FertiPro N.V
• Kitazato Corporation
• PerkinElmer, Inc.
• Natera
• Takara Bio, Inc.
• iGLS
• CiceroDx

Market Segmentation

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:

• In Vitro Fertilization Test Market, by Test Type
  • Sperm Aneuploidy Test
  • Genetic Compatibility Test
  • Preimplantation Genetic Testing
  • Endometrial Receptivity Analysis
  • Noninvasive Prenatal Testing
  • Others
• In Vitro Fertilization Test Market, by End User
  • Fertility Clinics
  • Hospitals
  • Others

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Click Here to View Full Report Table of Contents

Buy this Research Report@ https://www.novaoneadvisor.com/report/checkout/6294

You can place an order or ask any questions, please feel free to contact at sales@novaoneadvisor.com | +1 9197 992 333